Loading...
Imaging outcome measures for progressive multiple sclerosis trials
Imaging markers that are reliable, reproducible and sensitive to neurodegenerative changes in progressive multiple sclerosis (MS) can enhance the development of new medications with a neuroprotective mode-of-action. Accordingly, in recent years, a considerable number of imaging biomarkers have been...
Saved in:
| Published in: | Mult Scler |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5650056/ https://ncbi.nlm.nih.gov/pubmed/29041865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458517729456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|